TETRATHERIX LIMITED — Investor Relations & Filings

Tetratherix Limited is a regenerative medicine company focused on the development of advanced synthetic scaffolds for bone and tissue repair. The company utilizes proprietary polymer technology to create biocompatible, resorbable materials that mimic the natural extracellular matrix, providing a structural framework for cellular attachment and tissue regeneration. Its primary product line includes synthetic bone graft substitutes designed for use in orthopedic, dental, and maxillofacial surgical procedures. These scaffolds are engineered with high porosity to facilitate vascularization and are gradually replaced by natural bone during the healing process. Tetratherix aims to provide clinical solutions that enhance the body's innate ability to repair complex bone voids and soft tissue defects through innovative material science.